SCHEMBL26415564

SCHEMBL26415564

c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc4oc5cc(-c6ccc(N(c7ccccc7)c7ccccc7)cc6)ccc5c34)n2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.32
L3MBTL1 Q9Y468 3/20 0.32
GAA P10253 1/20 0.32
ADORA3 P0DMS8 1/20 0.32
ALOX15 P16050 1/20 0.32
ADORA2A P29274 1/20 0.32
ADORA2B P29275 1/20 0.32
ADORA1 P30542 1/20 0.32
MAPT P10636 7/20 0.32
ALDH1A1 P00352 5/20 0.32
HPGD P15428 4/20 0.32
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
HCRTR1 O43613 1/20 0.32
ABCG2 Q9UNQ0 1/20 0.32
CRHR1 P34998 1/20 0.32
KDM4E B2RXH2 5/20 0.32
SMN1; SMN2 Q16637 4/20 0.32
LMNA P02545 2/20 0.32
GLA P06280 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26415577 1.00 TSHR (0.32) TSHRL3MBTL1GAAADORA3ALOX15
SCHEMBL24255609 1.00 TSHR (0.32) TSHRL3MBTL1GAAADORA3ALOX15
SCHEMBL25975511 1.00 TSHR (0.32) TSHRL3MBTL1GAAADORA3ALOX15
SCHEMBL25975498 0.99 MAPT (0.33) TSHRL3MBTL1GAAADORA3ALOX15
SCHEMBL25975513 0.98 HCRTR1 (0.35) TSHRL3MBTL1MAPTALDH1A1HPGD
SCHEMBL25975494 0.95 MAPT (0.32) TSHRL3MBTL1GAAADORA3ALOX15
SCHEMBL24255591 0.95 MAPT (0.33) TSHRL3MBTL1ADORA3ALOX15ADORA2A
SCHEMBL26420463 0.95 MAPT (0.33) TSHRL3MBTL1ADORA3ALOX15ADORA2A
SCHEMBL24255592 0.95 MAPT (0.33) TSHRL3MBTL1ADORA3ALOX15ADORA2A
SCHEMBL24574966 0.94 ALDH1A1 (0.36) TSHRL3MBTL1MAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337529-A1 ORGANIC LIGHT-EMITTING DEVICE AND COMPOSITION FOR FORMING ORGANIC MATERIAL LAYER LT MATERIALS CO., LTD. (KR) 2023-10-19 US disclosed
US-20230337529-A1 ORGANIC LIGHT-EMITTING DEVICE AND COMPOSITION FOR FORMING ORGANIC MATERIAL LAYER LT MATERIALS CO., LTD. (KR) 2023-10-19 US disclosed
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-10-05 US disclosed
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-10-05 US disclosed
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE ORC3, CRY1, SUN2 TSHR 4730/4885L3MBTL1 1689/4885GAA 2232/4885
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE CRY1, ORC3, ODC1 TSHR 4641/4885L3MBTL1 2788/4885GAA 2294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.